Table 3.
Tumor characteristics of Pacific Island patients with HCC
PI-born (n = 92) | US-born (n = 153) | P value | Unadjusted OR, 95%CI | ||
---|---|---|---|---|---|
Mean size of primary tumor (cm) | 6.49 ( 5.01) | 6.58 ( 4.84) | P = 0.90 | ||
Size ≥ 5cm | 44 (48%) | 79 (52%) | P = 0.58 | 0.86 (0.51–2.11) | |
Size ≥ 10cm | 25 (27%) | 37 (24%) | P = 0.61 | 1.17 (0.65–2.11) | |
Multiple tumors | 37 (40%) | 52 (34%) | P = 0.33 | 1.31 (0.77–2.23) | |
Bilateral tumors | 14 (18%) | 24 (17%) | P = 0.92 | 1.04 (0.50–2.15) | |
Met Milan criteria | 38 (41%) | 65 (42%) | P = 0.78 | 0.95 (0.56–1.61) | |
Cirrhosis | 76 (84%) | 107 (70%) | P = 0.02 | 2.28 (1.17–4.45) | |
BCLC stage | 0 | 1 (1%) | 6 (4%) | P = 0.22 | 0.26 (0.03–2.24) |
A | 30 (33%) | 53 (35%) | P = 0.70 | 0.89 (0.52–1.55) | |
B | 36 (39%) | 64 (42%) | P = 0.63 | 0.87 (0.52–1.48) | |
C | 11 (12%) | 14 (9%) | P = 0.52 | 1.33 (0.57–3.07) | |
D | 14 (15%) | 14 (9%) | P = 0.16 | 1.76 (0.80–3.87) |
HCC: Hepatocellular carcinoma; PI-born: Pacific Island-born; BCLC: barcelona clinic liver cancer.